109 related articles for article (PubMed ID: 8039272)
1. Haemodynamic, renal and hormonal responses to enalkiren in four patients with post-surgical oliguria.
Jackson B; Liu G; Perich RB; Paxton D; McNicols L; Gutteridge G; Johnston CI
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):163-6. PubMed ID: 8039272
[TBL] [Abstract][Full Text] [Related]
2. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans.
Cordero P; Fisher ND; Moore TJ; Gleason R; Williams GH; Hollenberg NK
Hypertension; 1991 Apr; 17(4):510-6. PubMed ID: 2013477
[TBL] [Abstract][Full Text] [Related]
3. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK
Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
5. Effects of renin inhibition in systemic hypertension.
Anderson PW; Do YS; Schambelan M; Horton R; Boger RS; Luther RR; Hsueh WA
Am J Cardiol; 1990 Dec; 66(19):1342-7. PubMed ID: 2244565
[TBL] [Abstract][Full Text] [Related]
6. Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys.
Lenz T; Sealey JE; Maack T; James GD; Heinrikson RL; Marion D; Laragh JH
Am J Physiol; 1991 Apr; 260(4 Pt 2):R804-10. PubMed ID: 2012251
[TBL] [Abstract][Full Text] [Related]
7. Low-dose dopamine in critically ill oliguric patients: the influence of the renin-angiotensin system.
Marik PE
Heart Lung; 1993; 22(2):171-5. PubMed ID: 8449762
[TBL] [Abstract][Full Text] [Related]
8. Identical hemodynamic and hormonal responses to 14-day infusions of renin or angiotensin II in conscious rats.
Hu L; Catanzaro DF; Pitarresi TM; Laragh JH; Sealey JE
J Hypertens; 1998 Sep; 16(9):1285-98. PubMed ID: 9746116
[TBL] [Abstract][Full Text] [Related]
9. Intrarenal angiotensin II formation in humans. Evidence from renin inhibition.
Fisher ND; Allan DR; Gaboury CL; Hollenberg NK
Hypertension; 1995 May; 25(5):935-9. PubMed ID: 7737730
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Delabays A; Nussberger J; Porchet M; Waeber B; Hoyos P; Boger R; Glassman H; Kleinert HD; Luther R; Brunner HR
Hypertension; 1989 Jun; 13(6 Pt 2):941-7. PubMed ID: 2661434
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of three different potent renin inhibitors in primates.
Clozel JP; Fischli W
Hypertension; 1993 Jul; 22(1):9-17. PubMed ID: 8319997
[TBL] [Abstract][Full Text] [Related]
12. Impact of gender on the renal response to angiotensin II.
Miller JA; Anacta LA; Cattran DC
Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.
Gupta SK; Granneman GR; Boger RS; Hollenberg NK; Luther RR
Drug Metab Dispos; 1992; 20(6):821-5. PubMed ID: 1362933
[TBL] [Abstract][Full Text] [Related]
14. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
[TBL] [Abstract][Full Text] [Related]
15. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
[TBL] [Abstract][Full Text] [Related]
16. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
Davidson D; Stalcup SA
J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
[TBL] [Abstract][Full Text] [Related]
17. Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.
Boger RS; Glassman HN; Cavanaugh JH; Schmitz PJ; Lamm J; Moyse D; Cohen A; Kleinert HD; Luther RR
Hypertension; 1990 Jun; 15(6 Pt 2):835-40. PubMed ID: 2190927
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
[TBL] [Abstract][Full Text] [Related]
19. Renin inhibition with A-64662: effect on blood pressure and hormonal response in man.
Bursztyn M; Gavras I; Tifft CP; Bauer JH; Melby JC; Gavras H
J Hypertens Suppl; 1989 Dec; 7(6):S306-7. PubMed ID: 2698944
[TBL] [Abstract][Full Text] [Related]
20. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
